Mediclinic International plc
MEI
Classifica tra le azioni
#4308
Mediclinic International plc is a prominent healthcare provider that, through... Mediclinic International plc is a prominent healthcare provider that, through its various subsidiaries, manages and operates private hospital facilities. Operating under its well-known Mediclinic and Hirslanden brands, the firm delivers a broad spectrum of specialized and comprehensive healthcare services. Its extensive global network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. This network comprises 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, and 2 mental health facilities, which collectively feature 453 operating theatres and approximately 11,538 inpatient beds. Beyond direct patient care, Mediclinic also offers a range of auxiliary and support services, including treasury functions, medical equipment sourcing and procurement, emergency medical response, general management, food and catering, healthcare administration, and debt recovery. Furthermore, the company handles the management of its healthcare personnel and maintains its property portfolio. Its operations also extend to managing intellectual property and engaging in the medical supply and procurement sector. Established in 1983, the company's headquarters are located in Stellenbosch, South Africa.
Prezzo delle azioni
$6.02
Ultima sincronizzazione: 2023-05-26
Capitalizzazione di mercato
$3.60B
Variazione (1 giorno)
-18.50%
Variazione (1 anno)
0.00%
Paese
ZA
Scambia Mediclinic International plc (MEI)
Categoria
Healthcare
Rapporto P/B per Mediclinic International plc (MEI)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Mediclinic International plc, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Mediclinic International plc da 2002 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2022 | 0.85 | 15.47% |
| 2021 | 0.74 | 12.24% |
| 2020 | 0.66 | -9.96% |
| 2019 | 0.73 | -45.93% |
| 2018 | 1.35 | 5.74% |
| 2017 | 1.28 | -16.27% |
| 2016 | 1.53 | -70.46% |
| 2015 | 5.17 | -20.83% |
| 2014 | 6.53 | -22.20% |
| 2013 | 8.39 | -31.19% |
| 2012 | 12.20 | -3.21% |
| 2011 | 12.60 | -24.48% |
| 2010 | 16.69 | 8.32% |
| 2009 | 15.41 | 65.25% |
| 2008 | 9.32 | -82.55% |
| 2007 | 53.43 | 6.22% |
| 2006 | 50.30 | 97.83% |
| 2005 | 25.43 | -15.07% |
| 2004 | 29.94 | -25.14% |
| 2003 | 39.99 | -34.37% |
| 2002 | 60.94 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| -15.9433 | - |
US
|
|
| - | - |
DE
|
|
| 4.8701 | - |
US
|
|
| 8.8163 | - |
SA
|
|
| 4.6058 | - |
BR
|
